Characterizing PTSD symptom profiles in special forces operators and support personnel: Justification for a precision medicine approach

Abstract: Given the large number and diverse types of PTSD symptoms, examination of subtypes within the comprehensive PTSD criteria is necessary. This is especially true for subpopulations of active-duty service members such as specialized military units that undergo assessment and selection, receive extensive training, and have significant operational experience and trauma exposure. The current study identified PTSD subtypes in 16,284 U.S. Special Operations Forces (SOF) personnel who completed the Preservation of the Force and Family Needs Assessment Survey. Results identified a 4-profile solution. When stratifying the sample by occupation type (Operator vs Support), findings suggest that SOF Support personnel symptom presentations are primarily characterized by dysphoric and negative alterations in cognitions and mood symptoms. In contrast, SOF Operator personnel symptoms are best characterized by traditional profiles, consistent with the existing PTSD subtype literature. Results provide support for pursuing precision medicine approaches based on PTSD symptom profiles.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.